Legal Affairs

Turkish Parliament Legalizes Medical Cannabis Sales

ANKARA – In a pivotal decision, the Turkish Parliament has passed a groundbreaking law establishing the controlled sale of low-THC medical cannabis products in licensed pharmacies, representing a transformative shift in the nation's healthcare system. ...

Psilocybin Law Reforms Gain Momentum Across the United States

LOS ANGELES- Efforts to reform psilocybin laws are accelerating nationwide, with several states making significant strides toward decriminalization or legalization of the psychoactive compound found in "magic mushrooms."​ In Colorado, voters approved Proposition 122 in ...

Turkish Parliament Legalizes Medical Cannabis Sales

ANKARA – In a pivotal decision, the Turkish Parliament has passed a groundbreaking law establishing the controlled sale of low-THC medical cannabis products in licensed pharmacies, representing a transformative shift in the nation's healthcare system. ...

Cardiol Therapeutics Closes $22 Million Bought Deal Offering

ONTARIO–Cardiol Therapeutics Inc. (TSX: CRDL), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce the closing of its previously announced "bought deal" short form prospectus ...

Aleafia Health Reports 2021 First Quarter Results

TORONTO–Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) reported its financial results for the three months ended March 31, 2021. “This quarter saw us achieve important executional breakthroughs as we realized the exponential increase of our ...

TerrAscend Opens Largest Apothecarium on the East Coast

NEW YORK and TORONTO–TerrAscend Corp. (CSE:TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the grand opening of its second New Jersey medical cannabis dispensary. The 6,500 square foot dispensary, located at 1865 ...

Entheon Biomedical Uplists on OTCQB Venture Market

VANCOUVER, B.C.– Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: "1XU1"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces it has been approved for trading on the OTCQB Venture Market effective ...

Subscribe To Our Newsletter